MSN Life Sciences Private Ltd (MSN Group)

Overview

MSN Life Sciences is part of the MSN Group, founded in 2003 by Dr. MSN Reddy and headquartered in Hyderabad. The group runs 19 API and 8 finished-dosage plants in India, the USA and Indonesia, has a large in-house R&D centre, and offers contract manufacturing of finished dosages. MSN Life Sciences holds active US Type II DMFs for Abaloparatide, Difelikefalin, Etelcalcetide, Exenatide, Icatibant, Linaclotide, Plecanatide, Semaglutide, Sincalide, Teriparatide, Tirzepatide. FDA has issued a Form 483 to the group's MSN Laboratories Unit-II API site.

Capabilities

• Peptide API development
• API manufacturing
• Finished dosage manufacturing
• FDF contract manufacturing
• Regulatory filings

Quality signals

Sources

• msnlabs.com/
• msnlabs.com/about-us/
• fda.gov/drugs/drug-master-files-dmfs/list-drug-master-files-dmfs
• fda.gov/about-fda/msn-laboratories-private-limited-unit-ii